871716-67-5Relevant academic research and scientific papers
PROTEIN SECRETION INHIBITORS
-
Paragraph 00205, (2022/03/09)
Provided herein are secretion inhibitors, such as inhibitors of Sec61 for example of Formula (I), methods for their preparation, related pharmaceutical compositions, and method for using the same.
THIAZOLE DERIVATIVES AS PROTEIN SECRETION INHIBITORS
-
Paragraph 00260; 00340, (2020/09/12)
Provided herein are secretion inhibitors, such as inhibitors of Sec61, methods for their preparation, related pharmaceutical compositions, and methods for using the same, wherein the compound has a structure of Formula (I), (II), or (III).
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors
Dai, Chaoyang,Li, Dansu,Popovici-Muller, Janeta,Zhao, Lianyun,Girijavallabhan, Vinay M.,Rosner, Kristin E.,Lavey, Brian J.,Rizvi, Razia,Shankar, Bandarpalle B.,Wong, Michael K.C.,Guo, Zhuyan,Orth, Peter,Strickland, Corey O.,Sun, Jing,Niu, Xiaoda,Chen, Shiying,Kozlowski, Joseph A.,Lundell, Daniel J.,Piwinski, John J.,Shih, Neng-Yang,Siddiqui, M. Arshad
scheme or table, p. 3172 - 3176 (2011/06/24)
TNF-α converting enzyme (TACE) inhibitors are promising agents to treat inflammatory disorders and cancer. We have investigated novel tartrate diamide TACE inhibitors where the tartrate core binds to zinc in a unique tridentate fashion. Incorporating (R)-
